Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cardiovascular Risk Assessment in HIV-Infected Patients

Cardiovascular Risk Assessment in HIV-Infected Patients AbstractFrom the onset of the first case until now, HIV infection is one of the most studied pathologies in the medical field, due to the incompletely known action of the virus per se, as well as the comorbidities associated with it. Currently, a field of interest in research is occupied by cardiovascular comorbidities, being more and more frequent at PLWH. From the pathophysiological mechanisms of action, the traditional and modern CV risk factors, the scores with relative predictability to the adverse effects of ARV therapy, CVD at PLWH represent an incomplete studied field, which requires further investigation. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png ARS Medica Tomitana de Gruyter

Cardiovascular Risk Assessment in HIV-Infected Patients

Loading next page...
 
/lp/de-gruyter/cardiovascular-risk-assessment-in-hiv-infected-patients-FD1hsOLR8o
Publisher
de Gruyter
Copyright
© 2020 Zekra Lucia et al., published by Sciendo
ISSN
1841-4036
eISSN
1841-4036
DOI
10.2478/arsm-2020-0002
Publisher site
See Article on Publisher Site

Abstract

AbstractFrom the onset of the first case until now, HIV infection is one of the most studied pathologies in the medical field, due to the incompletely known action of the virus per se, as well as the comorbidities associated with it. Currently, a field of interest in research is occupied by cardiovascular comorbidities, being more and more frequent at PLWH. From the pathophysiological mechanisms of action, the traditional and modern CV risk factors, the scores with relative predictability to the adverse effects of ARV therapy, CVD at PLWH represent an incomplete studied field, which requires further investigation.

Journal

ARS Medica Tomitanade Gruyter

Published: Feb 1, 2020

Keywords: Cardiovascular; risk factors; HIV; patients; comorbidities; scores; heart failure; antiretroviral therapy

There are no references for this article.